Vyne Therapeutics Inc (VYNE) Stock Analysis

Vyne Therapeutics Inc (VYNE) is a publicly traded company in the HEALTHCARE sector. It trades at $0.68, carries a market capitalization of $22.74M. This page summarizes the public market data, fundamentals, and frequently asked questions for VYNE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Vyne Therapeutics Inc currently has a Bullish sentiment score of 0.31.

About Vyne Therapeutics Inc

Vyne Therapeutics Inc. is a biopharmaceutical company based in Bridgewater, New Jersey, focused on creating innovative therapies for dermatological conditions. With a promising pipeline targeting significant unmet medical needs in skin diseases, the company employs its proprietary technology and therapeutic platforms to enhance its treatment solutions. Vyne's dedication to advancing the management of dermatological disorders underscores its potential to improve patient outcomes and quality of...

GNG Research Analysis

GNG Research scores Vyne Therapeutics Inc (VYNE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VYNE.

Frequently Asked Questions

Does VYNE pay dividends?

Vyne Therapeutics Inc (VYNE) does not currently pay a regular dividend.

What is VYNE's market cap?

Vyne Therapeutics Inc (VYNE) has a market capitalization of $22.74M with a current stock price of $0.68.